Inventor · disambiguated record
José Medina Echeverz
Also filed as: MEDINA ECHEVERZ JOSE · MEDINA ECHEVERZ JOSÉ
4 granted patents·7 pending applications·10 citations·filing 2010–2023
64Inventor score
Top patents by PatentIndex Score
11 records- 0172US12390515B2Therapy for treating cancer with an intratumoral or intravenous administration of a recombinant MVA encoding 4-1BBL (CD137L) and/or CD40LBAVARIAN NORDIC AS·Filed 2019·Granted Aug 19, 2025·1 cites·12 claims
- 0268US8771664B2Compositions comprising apolipoprotein A polypeptide and interleukin 15, and methods of treatment using the sameBERRAONDO LOPEZ PEDRO·Filed 2010·Granted Jul 8, 2014·9 cites·22 claims
- 0367US11723964B2Combination therapy for treating cancer with an antibody and intravenous administration of a recombinant MVABAVARIAN NORDIC AS·Filed 2022·Granted Aug 15, 2023·0 cites·9 claims
- 0462US2025002606A1Combination Therapy for Treating Cancer with an Antibody and Intravenous Administration of a Recombinant MVABAVARIAN NORDIC AS·Filed 2023·Application pending·0 cites
- 0560US2025387463A1Recombinant Modified saRNA (VRP) and Vaccinia Virus Ankara (MVA) Prime-Boost RegimenBAVARIAN NORDIC AS·Filed 2023·Application pending·0 cites
- 0659US11273211B2Combination therapy for treating cancer with an intravenous administration of a recombinant MVA and an antibodyBAVARIAN NORDIC AS·Filed 2018·Granted Mar 15, 2022·0 cites·9 claims
- 0758US2025049903A1Therapy for Modulating Immune Response with Recombinant MVA Encoding IL-12BAVARIAN NORDIC AS·Filed 2022·Application pending·0 cites
- 0850US2023233670A1A Recombinant Modified Vaccinia Virus (MVA) Vaccine Against Coronavirus DiseaseBAVARIAN NORDIC AS·Filed 2021·Application pending·0 cites
- 0946US2023190922A1Recombinant MVA Viruses for Intratumoral and/or Intravenous Administration for Treating CancerBAVARIAN NORDIC AS·Filed 2020·Application pending·0 cites
- 1045US2023059344A1Medical Uses of 4-1BBL Adjuvanted Recombinant Modified Vaccinia Virus Ankara (MVA)BAVARIAN NORDIC AS·Filed 2020·Application pending·0 cites
- 1144US2024269254A1Combination Therapy for Treating Cancer with an Intravenous Administration of a Recombinant MVA and an Immune Checkpoint Antagonist or AgonistBAVARIAN NORDIC AS·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →